Free Trial

Halozyme Therapeutics (HALO) Insider Trading & Ownership

$62.17
+1.24 (+2.04%)
(As of 08/21/2024 ET)

Halozyme Therapeutics (NASDAQ:HALO) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
2.40%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
4
Amount Of
Insider Selling
(Last 12 Months)
$8.09 M
Get HALO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Halozyme Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

HALO Insider Buying and Selling by Quarter

Halozyme Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/21/2024Michael J LabarreSVPSell10,000$61.75$617,500.00  
8/14/2024Matthew L PosardDirectorSell9,881$57.70$570,133.70  
8/12/2024Matthew L PosardDirectorSell10,000$55.72$557,200.00  
7/24/2024Michael J LabarreSVPSell10,000$55.12$551,200.00  
7/22/2024Nicole LabrosseCFOSell5,000$53.93$269,650.00  
6/27/2024Nicole LabrosseCFOSell10,000$51.93$519,300.00  
6/11/2024Matthew L PosardDirectorSell10,000$50.01$500,100.00  
5/22/2024Michael J LabarreSVPSell10,000$45.38$453,800.00  
4/17/2024Michael J LabarreSVPSell10,000$38.49$384,900.00  
3/12/2024Michael J LabarreSVPSell10,000$41.64$416,400.00  
2/28/2024Michael J LabarreSVPSell10,000$39.55$395,500.00  
12/12/2023Michael J LabarreSVPSell10,000$39.63$396,300.00  
10/17/2023Michael J LabarreSVPSell10,000$36.52$365,200.00  
9/19/2023Michael J LabarreSVPSell10,000$39.10$391,000.00  
8/31/2023Helen TorleyCEOSell10,000$42.82$428,200.00  
8/29/2023Helen TorleyCEOSell10,000$42.40$424,000.00  
8/22/2023Michael J LabarreSVPSell10,000$42.41$424,100.00  
8/22/2023Michael J LabarreSVPSell10,000$42.41$424,100.00  
(Data available from 1/1/2013 forward)

HALO Insider Trading Activity - Frequently Asked Questions

Who is on Halozyme Therapeutics's Insider Roster?
What percentage of Halozyme Therapeutics stock is owned by insiders?

2.40% of Halozyme Therapeutics stock is owned by insiders. Learn more on HALO's insider holdings.

Which Halozyme Therapeutics insiders have been selling company stock?

The following insiders have sold HALO shares in the last 24 months: Helen Torley ($5,270,664.86), James M Daly ($874,500.00), Jeffrey William Henderson ($477,100.00), Matthew L Posard ($2,772,833.70), Michael J Labarre ($8,556,300.00), and Nicole Labrosse ($1,182,381.50).

How much insider selling is happening at Halozyme Therapeutics?

Insiders have sold a total of 403,467 Halozyme Therapeutics shares in the last 24 months for a total of $19,133,780.06 sold.


This page (NASDAQ:HALO) was last updated on 8/22/2024 by MarketBeat.com Staff

From Our Partners